妊娠期肝内胆汁淤积症患者血脂、肝功能和雌激素水平的变化及临床意义*

doi:10.3969/j.issn.1672-5069.2019.06.021

摘要/Abstract

摘要： 目的探讨妊娠期肝内胆汁淤积症（ICP）患者血脂、肝功能和雌激素水平的变化及意义。方法 2014年3月~2018年9月本院就诊的120例ICP患者,其中轻度组81例,重度组39例,另选择同期健康孕妇50例作为对照组。采用放射免疫法测定血清雌二醇和雌三醇及总胆汁酸（TBA）水平。结果重度ICP患者血甘油三酯（TG）、总胆固醇（CHOL）和低密度脂蛋白（LDL）水平分别为（4.9±0.8） mmol/L、（7.9±1.0） mmol/L和（4.1±1.3）mmol/L,显著高于轻度组的（3.3±0.7） mmol/L、（5.7±0.8） mmol/L和（3.2±0.7） mmol/L或对照组的[（2.3±0.5）mmol/L、（4.5±0.6） mmol/L和（2.1±0.5） mmol/L,P<0.05],重度组患者血TG、CHOL和LDL水平显著高于轻度组,差异具有统计学意义（P<0.05）;重度ICP患者血清AST、ALT和TBA水平分别为（93.2±43.5） U/L、（87.7±52.3）U/L和（65.3±37.5） μmol/L,显著高于对照组的（38.3±7.4） U/L、（41.4±6.5） U/L和（8.9±5.2） μmol/L或者轻度ICP组的[（43.4±11.6） U/L、（39.3±11.5） U/L和（15.2±6.5） μmol/L,P<0.05];重度ICP患者血清雌二醇和雌三醇水平分别为（83.6±13.5） ng/L和（47.82±20.19） ng/L,显著高于轻度组的（67.2±11.4） ng/L和（39.2±15.4） ng/L或对照组的[（43.2±7.5） ng/L和（23.3±12.6） ng/L,P<0.05];重度组患者早产、新生儿窒息和宫内窘迫发生率分别为18.0%、12.8%和12.8%,显著高于轻度组的11.1%、8.6%和9.9%,也显著高于对照组的2.0%、0.0%和2.0%（P<0.05）。结论 ICP患者血脂、肝功能和雌激素水平发生了显著的变化,对诊断和治疗具有重要的意义。

关键词: 妊娠期肝内胆汁淤积症, 血脂, 雌激素

Abstract: Objective The aim of this stud was to investigate the changes and its clinical significance of serum lipids,liver function index and estrogen levels in patients with intrahepatic cholestasis of pregnancy （ICP）. Methods The clinical data of 120 patients with ICP who were admitted in our hospital between March 2014 and September 2018 were analyzed. According to the severity of ICP,there were 81 patients with mild and 39 patients with severe ICP. Another 50 healthy pregnant women in the same period were selected as the control group. Serum estradiol,estratriol and total bile acid（TBA） levels were detected by RIA. Results Blood triglyceride （TG）,total cholesterol （CHOL） and low density lipoprotein （LDL） levels in patients with severe ICP were （4.9±0.8） mmol/L,（7.9±1.0） mmol/L and （4.1±1.3） mmol/L,significantly higher than （3.3±0.7） mmol/L,（5.7±0.8） mmol/L and （3.2±0.7） mmol/L in patients with mild ICP or [（2.3±0.5） mmol/L,（4.5±0.6） mmol/L and （2.1±0.5） mmol/L,P<0.05] in healthy women （P<0.05）;serum aspartate aminotransferase （AST）,alanine aminotransferase and TBA levels in patients with severe ICP were（93.2±43.5） U/L,（87.7±52.3） U/L and（65.3±37.5） μmol/L,significantly higher than （38.3±7.4） U/L,（41.4±6.5） U/L and（8.9±5.2） μmol/L in healthy individuals or [（43.4±11.6） U/L,（39.3±11.5） U/L and（15.2±6.5） μmol/L,respectively,P<0.05] in patients with mild ICP;serum estradiol and estratriol levels in patients with severe ICP were （83.6±13.5） ng/L and （47.82±20.19） ng/L,significantly higher than （67.2±11.4） ng/L and （39.2±15.4） ng/L in patients with mild ICP or [（43.2±7.5） ng/L and （23.3±12.6） ng/L,P<0.05] in the control;the incidences of preterm delivery,neonatal asphyxia and intrauterine distress in patients with severe ICP were 18.0%,12.8% and 12.8%,much higher than 11.1%,8.6% and 9.9% in patients with mild ICP or 2.0%,0.0% and 2.0% in the control（P<0.05）. Conclusion The blood lipids,liver function tests and estrogen levels in patients with ICP changes greatly,which might help evaluate the severity of ICP and guide clinical managements.

Key words: Intrahepatic cholestasis of pregnancy, Blood lipids, Estrogen

汤人夷, 胡群凤, 彭莉晴. 妊娠期肝内胆汁淤积症患者血脂、肝功能和雌激素水平的变化及临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 860-863.

Tang Renyi, Hu Qunfeng, Peng Liqing.. Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance[J]. Journal of Practical Hepatology, 2019, 22(6): 860-863.

参考文献

[1] 杜巧玲,段涛. 胆汁酸与妊娠期肝内胆汁淤积症发病机制关系的研究进展. 中华妇产科杂志,2013,48(2):141-143.
[2] Ovadia C,Lovgren-Sandblom A,Edwards LA,et al.Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy:Case series and mechanism of action. J Clin Apher,2018,33(6):638-644.
[3] GencosmanogluTürkmen G,VuralYilmaz Z,Daglar K,et al. Low serum vitamin D level is associated with intrahepatic cholestasis of pregnancy. J ObstetGynaecol Res,2018,44(9):1712-1718.
[4] 热依汗古丽·买买提,刘海燕,韩文晖,等. 妊娠期肝内胆汁淤积症对早产发生率的影响. 中华流行病学杂志,2017,38(10):1415-1418.
[5] 刘晓媛,姚荧,汪涛,等. 妊娠期肝内胆汁淤积症不良妊娠结局与细胞死亡方式相关性的研究进. 中华妇产科杂志,2018,53(7):500-503.
[6] 孙彩萍,张珂,王倩,等. 妊娠期肝内胆汁淤积症发病危险因素及其对妊娠结局的影响分析. 中华全科医学,2017,15(7):1130-1132.
[7] Wood AM,Livingston EG,Hughes BL,et al.Intrahepatic chol-estasis of pregnancy:A review of diagnosis and management. Obstet Gynecol Surv,2018,73(2):103-109.
[8] Kong X,Kong Y,Zhang F,et al.Expression and significance of dendritic cells and Th17/Treg in serum and placental tissues of patients with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med,2018,31(7):901-906.
[9] Kirbas A,Biberoglu E,Daglar K,et al.Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol,2014,180(3):12-15.
[10] Kowalska-Kańka A,Maciejewski T,Niemiec K T.The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn. Medycyna Wieku Rozwojowego,2013,17(3):232-245.
[11] Suresh I,Tr V,Hp N.Predictors of fetal and maternal outcome in the crucible of hepatic dysfunction during pregnancy. Gastroenterol Res,2017,10(1):21-27.
[12] Maev IV,Andreev DN,Dicheva DT,et al.Intrahepatic cholestasis of pregnancy:State-of-the-art. Klin Med (Mosk),2015,93(6):25-30.
[13] Rao ZZ,Zhang XW,Ding YL,et al.MiR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy:Role of PXR/MRP3.PLoS One,2017,12(6):e0178702.
[14] Bao W,Dar S,Zhu Y,et al.Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus:A longitudinal study. J Diabetes,2018,10(6):487-495
[15] Basaranoglu S,Agacayak E,Ucmak F,et al.The role of vitamin B1-B2 and plasma lipid profile in intrahepatic cholestasis of pregnancy. J Perinat Med,2017,45(4):461-465.
[16] Pecks U,Rath W,Kleine-Eggebrecht N,et al.Maternal serum lipid,estradiol,and progesterone levels in pregnancy,and the impact of placental and hepatic pathologies. Geburtshilfe Frauenheilkd,2016,76(7):799-808.
[17] Martineau MG,Raker C,Dixon PH,et al.The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance,dyslipidemia,and increased fetal growth. Diabetes Care,2015,38(2):243-248.
[18] Floreani A,Caroli D, Lazzari R,et al.Intrahepatic cholestasis of pregnancy:new insights into its pathogenesis. J Matern Fetal Neonatal Med,2013,26(14):1410-1415.
[19] Pecks U,Rath W,Kleine-Eggebrecht N,et al.Maternal serum lipid,estradiol,and progesterone levels in pregnancy,and the impact of placental and hepatic pathologies. Geburtshilfe Frauenheilkunde,2016,76(7):799-808.
[20] 徐晖,黄夏冰,伍涛. 妊娠期肝内胆汁淤积症患者相关生化指标的检测及临床意义. 中华全科医学,2017,15(7):1192-1193,1197.

妊娠期肝内胆汁淤积症患者血脂、肝功能和雌激素水平的变化及临床意义^*

Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[2]	严玲玲, 胡东辉, 黄艳芳. 腺苷蛋氨酸联合多烯磷酯酰胆碱治疗妊娠期肝内胆汁淤积症患者临床疗效初步研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 530-533.
[3]	张枫, 阎妍. 非酒精性脂肪性肝病患者血清载脂蛋白B水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(1): 61-64.
[4]	孙琳, 王丹, 吴冬寒. 肝内胆汁淤积症孕妇分娩结局研究[J]. 实用肝脏病杂志, 2018, 21(1): 133-134.
[5]	韩会娟, 王涛. 慢性乙型肝炎患者合并妊娠期肝内胆汁淤积症危险因素分析[J]. 实用肝脏病杂志, 2017, 20(3): 280-283.
[6]	柯盈月，崔盈盈，李权伦，袁学华. 妊娠期肝内胆汁淤积症患者血生化指标及其对围产儿预后的影响[J]. 实用肝脏病杂志, 2017, 20(2): 187-190.
[7]	任金晴, 徐亮, 张舰琼, 李萍, 刘勇钢, 周小莉, 宓余强. 急性病毒性肝炎患者肝功能指标与血脂的相关性研究^*[J]. 实用肝脏病杂志, 2017, 20(1): 38-41.
[8]	张改珍,任建军. MELD-Na评分对肝硬化患者血脂和预后的影响[J]. 实用肝脏病杂志, 2016, 19(6): 732-733.
[9]	何杰雄, 王鹏, 李静. 复方牛胎肝提取物治疗非酒精性脂肪性肝炎临床观察[J]. 实用肝脏病杂志, 2016, 19(5): 557-560.
[10]	靳伟杰, 谢永强, 刘刚. 酒精性肝硬化患者尿微量蛋白的变化[J]. 实用肝脏病杂志, 2016, 19(2): 221-222.
[11]	赵雷，张玮. 雌激素在慢性肝病发生发展中的作用研究现状^*[J]. 实用肝脏病杂志, 2015, 18(5): 563-566.
[12]	张志侨，王功遂，康凯夫，吴国标，王鹏. 慢性乙型肝炎患者血脂和血糖代谢异常发生率调查^*[J]. 实用肝脏病杂志, 2015, 18(4): 424-426.
[13]	徐亮, 李萍, 宓余强, 张弘, 王文志. 非酒精性脂肪性肝病患者血脂变化的流行病学调查[J]. 实用肝脏病杂志, 2012, 15(4): 286-288.
[14]	王春霞, 麦韵屏, 沙卫红, 王启仪. 体检人群非酒精性脂肪性肝病检出率及其相关因素分析^*[J]. 实用肝脏病杂志, 2012, 15(4): 289-290.
[15]	张婷婷，张振华，叶珺，张亚飞，张玲，夏国美，李旭. 雌激素受体α基因PvuⅡ多态性与慢性乙型肝炎患者干扰素-α早期应答的相关性研究*[J]. 实用肝脏病杂志, 2010, 13(4): 265-271.